Legal Counsel, International

About the role

BridgeBio is a global biotechnology company with our Global Headquarters located in San Francisco, USA, and our International HQ located in Zug, Switzerland. Since establishing our European presence in 2021, we've been building empowered, high-performing teams across countries - with experienced colleagues who move quickly, take ownership, and are fueling the company's international growth. At BridgeBio, you'll find an energetic and collaborative culture where pragmatism meets bold decision-making. We embrace uncertainty with confidence, guided by our commitment to making a meaningful impact for patients. Our people are trusted and empowered, united by urgency, purpose, and the drive to advance science for patients around the world. To learn more about our story and company culture, visit us at https://bridgebio.com

Responsibilities

• The legal work behind bringing medicines to patients is rarely one-dimensional. It spans commercial contracting, launch readiness, promotional review, digital channels, compliance, privacy, and the judgment to know when to move quickly and when to pause.
• This role is suited to a pragmatic lawyer who is excited by breadth, ownership, and the opportunity to help build scalable legal frameworks in a fast-moving biotech environment.
• Commercial Contracting & Day-to-Day Legal Support
• Draft, review, negotiate, and advise on a broad range of agreements, including supplier and vendor agreements, master services agreements, service agreements, NDAs/CDAs, technology and digital services contracts, and other ancillary commercial documents
• Provide day-to-day legal support across Commercial, Medical Affairs, Regulatory, Market Access, Finance and Supply Chain, on contractual and commercial, ensuring alignment with applicable laws, internal policies, and business objectives
• Advice on contract structuring, liability and risk allocation, and contract interpretation, and helping manage the full contracting lifecycle in partnership with business stakeholders
• Commercial Launch, Marketing & Promotional Review
• Support launch readiness and ongoing commercial operations across relevant European markets by advising on pre-marketing activities, field force materials, promotional reviews, patient support initiatives and operational readiness questions
• Support EU MLR (Medical, Legal, Regulatory) review for Legal International, ensuring promotional and medical materials meet EU and national requirements, giving clear, enabling advice on claims, fair balance, substantiation, and appropriate risk mitigation
• Support the development and maintenance of EU-specific promotional review guidelines and support training of cross-functional stakeholders on compliant pre-marketing and promotion practices
• Operational Excellence & Cross-Functional Partnership
• P

Additional Information

Mavericks Wanted When was the last time you achieved the impossible? If that thought feels overwhelming, you might want to pause here, but if it sparks excitement...read on In 2015, we pioneered a "moneyball for biotech" approach, pooling projects and promising early-stage research from academia together under one financial umbrella to reduce risk and unleash innovation. This model allows science and small teams of experts to lead the way. We build bridges to groundbreaking advancements in rare disease, and develop life-changing medicines for patients with unmet needs as fast as humanly possible. Together we define white space, push boundaries, and empower people to solve problems. If you're someone who defies convention, join us and work alongside some of the most respected minds in the industry. Together, we'll ask "why not?" and help reengineer the future of biopharma. At BridgeBio, we value curiosity and experimentation-including the ethical & thoughtful use of AI to improve clarity, speed, and quality of work. About BridgeBio Pharma, Inc. BridgeBio is a biopharmaceutical company dedicated to discovering, developing, and delivering transformative medicines for patients living with genetic diseases and genetically defined cancers. Since our founding in 2015, we have built a diverse portfolio of more than 20 drug development programs, ranging from early discovery to late-stage clinical trials, across multiple therapeutic areas including precision oncology, cardiology, endocrinology, neurology, and renal disease. We have already achieved regulatory approval for three therapies and continue to advance promising science from academia into meaningful treatments for patients worldwide.

Your Match

How well this role fits your profile.

Company Intel

What employees say

Worked at bridgebio? Share your experience